Treatment of Richter's transformation with novel therapies
A Bajwa, A Habib, AS Kittai - Current Hematologic Malignancy Reports, 2024 - Springer
Abstract Purpose of Review This review presents recently published clinical trial data and
ongoing investigations regarding the treatment of Richter's transformation (RT). Recent …
ongoing investigations regarding the treatment of Richter's transformation (RT). Recent …
Richter's transformation: Transforming the clinical landscape
A Barrett, N Appleby, H Dreau, CP Fox, T Munir… - Blood Reviews, 2023 - Elsevier
Richter transformation (RT) represents an aggressive histological transformation from
chronic lymphocytic leukaemia, most often to a large B cell lymphoma. It is characterised by …
chronic lymphocytic leukaemia, most often to a large B cell lymphoma. It is characterised by …
Practical management of Richter transformation in 2023 and beyond
CE Ryan, MS Davids - … Society of Clinical Oncology Educational Book, 2023 - ascopubs.org
While the past decade has witnessed unprecedented progress for patients with chronic
lymphocytic leukemia (CLL), outcomes for patients with Richter transformation (RT) remain …
lymphocytic leukemia (CLL), outcomes for patients with Richter transformation (RT) remain …
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia
Many patients with chronic lymphocytic leukemia (CLL) will develop treatment resistance to
Bruton tyrosine kinase (BTK) inhibitors. Phosphatidylinositol-3-kinase (PI3K) inhibitors …
Bruton tyrosine kinase (BTK) inhibitors. Phosphatidylinositol-3-kinase (PI3K) inhibitors …
Update on management of diffuse large B-cell lymphoma Richter's transformation
O Sośnia, B Puła - Acta Haematologica Polonica, 2024 - journals.viamedica.pl
Richter's transformation (RT) is defined as the development of an aggressive lymphoma in 2–
10% of patients with chronic lymphocytic leukemia (CLL). Despite significant advances in …
10% of patients with chronic lymphocytic leukemia (CLL). Despite significant advances in …
Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon
N Pham, CC Coombs, S O'Brien - Expert Review of Hematology, 2024 - Taylor & Francis
Introduction The therapeutic landscape for chronic lymphocytic leukemia/small lymphocytic
lymphoma (CLL/SLL) has significantly evolved over the past decade with dramatically …
lymphoma (CLL/SLL) has significantly evolved over the past decade with dramatically …
[HTML][HTML] Chronic lymphocytic leukemia: moving towards new horizons
E IO, ESH CLL - memoinoncology.com
The first-in-class, covalent BTK inhibitor ibrutinib has transformed the treatment of patients
with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). However …
with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). However …